GigaCloud Technology Inc Enters Definitive Share Purchase Agreement to Acquire New Classic Home Furnishings

GigaCloud Technology Inc Enters Definitive Share Purchase Agreement to Acquire New Classic Home Furnishings GlobeNewswire December 03, 2025 EL MONTE, Calif., Dec. 03, 2025 (GLOBE NEWSWIRE) — GigaCloud Technology Inc (Nasdaq: GCT) (“GigaCloud” or the “Company”), a pioneer of global end-to-end B2B technology solutions for large parcel merchandise, today announced that it has entered into […]

Premium Global Income Split Corp. Declares Monthly Distribution

Premium Global Income Split Corp. Declares Monthly Distribution GlobeNewswire December 03, 2025 TORONTO, Dec. 03, 2025 (GLOBE NEWSWIRE) — (TSX: PGIC; PGIC.PR.A) Premium Global Income Split Corp. has declared monthly distributions payable on December 31, 2025 to shareholders of record on December 15, 2025 in the following amounts per share: Share Class Ticker Amount Per

nCino Appoints Two New Independent Board Members

nCino Appoints Two New Independent Board Members Technology executives Andy Yasutake and Diego Dugatkin bring deep AI product innovation and expertise to nCino's Board of Directors GlobeNewswire December 03, 2025 WILMINGTON, N.C., Dec. 03, 2025 (GLOBE NEWSWIRE) — nCino, Inc. (NASDAQ: NCNO), the leading provider of intelligent, best-in-class banking solutions, today announced that it has

Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire December 03, 2025 BOSTON, Dec. 03, 2025 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, today announced that

Mulvihill Premium Yield Fund Declares Monthly Fund Distribution for Its ETF Class

Mulvihill Premium Yield Fund Declares Monthly Fund Distribution for Its ETF Class GlobeNewswire December 03, 2025 TORONTO, Dec. 03, 2025 (GLOBE NEWSWIRE) — (TSX: MPY) Mulvihill Premium Yield Fund has declared a monthly cash distribution for its ETF Class in the amount of $0.06400 per unit, payable on January 8, 2026 to unitholders of record

Mulvihill Canadian Bank Enhanced Yield ETF Declares Monthly Distribution

Mulvihill Canadian Bank Enhanced Yield ETF Declares Monthly Distribution GlobeNewswire December 03, 2025 TORONTO, Dec. 03, 2025 (GLOBE NEWSWIRE) — (TSX: CBNK) Mulvihill Canadian Bank Enhanced Yield ETF has declared a monthly cash distribution in the amount of $0.058333 per unit, payable on January 8, 2026, to unitholders of record on December 31, 2025. For

Mulvihill Enhanced Split Preferred Share ETF Declares Monthly Distribution

Mulvihill Enhanced Split Preferred Share ETF Declares Monthly Distribution GlobeNewswire December 03, 2025 TORONTO, Dec. 03, 2025 (GLOBE NEWSWIRE) — (TSX: SPFD) Mulvihill Enhanced Split Preferred Share ETF has declared a monthly cash distribution in the amount of $0.08333 per unit, payable on January 8, 2026 to unitholders of record on December 31, 2025. For

Premium Income Corporation Announces Monthly Distribution

Premium Income Corporation Announces Monthly Distribution GlobeNewswire December 03, 2025 TORONTO, Dec. 03, 2025 (GLOBE NEWSWIRE) — (TSX: PIC.A; PIC.PR.A) Premium Income Corporation has declared monthly distributions payable on December 31, 2025 to shareholders of record on December 15, 2025 in the following amounts per share: Share Class Ticker Amount Per Share Class A Shares

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire December 03, 2025 NEW YORK, Dec. 03, 2025 (GLOBE NEWSWIRE) — Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that on December 1, 2025, the Company granted inducement awards to purchase up to 15,500 shares of common stock

HealthEquity Reports Third Quarter Ended October 31, 2025 Financial Results

HealthEquity Reports Third Quarter Ended October 31, 2025 Financial Results GlobeNewswire December 03, 2025 Highlights of the third quarter include: Revenue increased 7% to $322.2 million. Net income per diluted share rose to $0.59 from $0.06 one year ago, and non-GAAP net income per diluted share increased 29% to $1.01. Total HSA Assets grew 15%

Scroll to Top